Fresenius Medcl Care Company Profile
What is the competitive landscape for FRESENIUS MEDCL CARE
FRESENIUS MEDCL CARE has three approved drugs.
There are three US patents protecting FRESENIUS MEDCL CARE drugs.
Summary for Fresenius Medcl Care
| US Patents: | 3 |
| Tradenames: | 3 |
| Ingredients: | 1 |
| NDAs: | 3 |
Drugs and US Patents for Fresenius Medcl Care
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Medcl Care | PHOSLO | calcium acetate | CAPSULE;ORAL | 021160-001 | Apr 2, 2001 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Fresenius Medcl Care | PHOSLYRA | calcium acetate | SOLUTION;ORAL | 022581-001 | Apr 18, 2011 | DISCN | Yes | No | 8,592,480 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fresenius Medcl Care | PHOSLO GELCAPS | calcium acetate | CAPSULE;ORAL | 021160-003 | Apr 2, 2001 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Fresenius Medcl Care | PHOSLO | calcium acetate | TABLET;ORAL | 019976-001 | Dec 10, 1990 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Fresenius Medcl Care
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Fresenius Medcl Care | PHOSLO | calcium acetate | TABLET;ORAL | 019976-001 | Dec 10, 1990 | 4,870,105 | ⤷ Start Trial |
| Fresenius Medcl Care | PHOSLO | calcium acetate | CAPSULE;ORAL | 021160-001 | Apr 2, 2001 | 4,870,105 | ⤷ Start Trial |
| Fresenius Medcl Care | PHOSLO GELCAPS | calcium acetate | CAPSULE;ORAL | 021160-003 | Apr 2, 2001 | 4,870,105 | ⤷ Start Trial |
| Fresenius Medcl Care | PHOSLO GELCAPS | calcium acetate | CAPSULE;ORAL | 021160-003 | Apr 2, 2001 | 6,875,445 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for FRESENIUS MEDCL CARE drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Oral Solution | 667 mg/5 mL | ➤ Subscribe | 2013-12-05 |
| ➤ Subscribe | Capsules | EQ 169 mg calcium | ➤ Subscribe | 2005-05-31 |
International Patents for Fresenius Medcl Care Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2009104774 | ⤷ Start Trial |
| South Korea | 101553719 | ⤷ Start Trial |
| European Patent Office | 2048948 | ⤷ Start Trial |
| China | 104095838 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Fresenius Medcl Care Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3752510 | LUC50026 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: VANZACAFTOR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREFERABLY A CALCIUM SALT THEREOF; AUTHORISATION NUMBER AND DATE: EU/1/25/1943 20250701 |
| 3752510 | CA 2025 00041 | Denmark | ⤷ Start Trial | PRODUCT NAME: VANZACAFTOR ELLER ET FARMACEUTISK ACCEPTABLELT SALT DERAF, FORTRINSVIS ET CALCIUM-SALT DERAF; REG. NO/DATE: EU/1/25/1943 20250701 |
| 2957286 | 1990003-4 | Sweden | ⤷ Start Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; FIRST MARKETING AUTHORIZATION NUMBER SE: EG EU/1/17/1179, 2017-07-21; PRV HAR I BESLUT DEN 16 JULI 2025 RAETTAT SKYDDSTIDEN I FOELJANDE TILLAEGGSSKYDD I ENLIGHET MED PMD:S BESLUT PMAE 7804/24: 1990003-4 2190008-9 |
| 0720599 | 300689 | Netherlands | ⤷ Start Trial | PRODUCT NAME: EZETIMIBE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, EN ATORVASTATINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER ATORVASTATINE CALCIUM TRIHYDRATE; NATIONAL REGISTRATION NO/DATE: RVG114373-114376 20141027; FIRST REGISTRATION: FR 2014091200122 20140912 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
